Corporate Archive: GlaxoSmithKline, Government reach civil settlement Page 1 of 2

Corporate News, Articles and Press Releases Bookmark Us

Home Home > GlaxoSmithKline Press Release > 2003

Company Airbus GlaxoSmithKline Press Releases Amazon AOL Apple AstraZeneca 16th April, 2003 ATT Boeing GlaxoSmithKline, Government reach civil settlement British-Telecom - (Gsk) Prescription Assistance Program Annual income under $42k Cisco to qualify CitiGroup www.myrxadvocate.com Coca-Cola Glaxosmithkline careers The Premier online Destination for Jobs paying Over $100K. Dell Search Now. Birth Defects Lawsuit Ebay www.TheLadders.com If you have given birth to a child with birth defects GlaxoSmithKline while on ... Glaxosmithkline Job -2006 www.awkolaw.com/drugs_paxilbirth -2005 Every Job. Everywhere. -2004 www.JobsOnline.net -2003 Birth Defects Lawsuit Google If you have given birth to a child with birth defects while Halliburton on ... Hewlett-Packard www.awkolaw.com/drugs_paxilbirth HSBC IBM GlaxoSmithKline, Government reach civil settlement Intel KPMG , PA., April 16, 2003 -- GlaxoSmithKline today announced it has reached a civil settlement with the U.S. Department of Justice, acting through the U.S. Attorney’s Office for Massachusetts, the Office of the Inspector McDonalds General of the US Department of Health and Human Services and the states. Microsoft Morgan-Stanley The sole issue at the heart of the investigation leading to the settlement was how GSK’s heritage companies Nestle interpreted an ambiguous aspect of the Medicaid Best Price Statute and how they applied that statute to limited arrangements with a single customer involving the repackaging of a small number of its products. Oracle Orange GSK continues to believe that its interpretation of the law was reasonable and in good faith. The company has agreed SAP to a civil settlement to avoid the delay and expense of a trial. In 2000, the government clarified its interpretation of this Shell ambiguous aspect of the statute, and each of the GSK heritage companies discontinued the arrangements in question. http://www.icaa.eu/company/GlaxoSmithKline/article/7897.html 8/23/2007 Corporate Archive: GlaxoSmithKline, Government reach civil settlement Page 2 of 2

Sony The company has cooperated fully with the U.S. Attorney’s office since receiving subpoenas on the matter in fall 2000. The arrangements at issue were made before the merger of SmithKline Beecham and Glaxo Wellcome in December Toyota 2000 and were terminated prior to the merger. Yahoo Under the settlement, GSK will pay $87.6 million to be divided among federal and state governments and entities eligible for Public Health Service pricing. Company Search Article Search The company made full provision for this settlement last year.

Ads by Google For further information, please contact: GSK Pharma GSK Careers GlaxoSmithKline enquiries UK Media Martin Sutton GSK Jobs Siobhán Lavelle Glaxo GSK David Mawdsley 020 8047 5502 020 8047 5502 020 8047 5502 US Media Nancy Pekarek Mary Anne Rhyne Patricia Seif (215) 751 7709 (919) 483 2839 (215) 751 7709 European Analyst/Investor Duncan Learmouth Philip Thomson Anita Kidgell 020 8047 5540 020 8047 5543 020 8047 5542 US Analyst/Investor Frank Murdolo Tom Curry (215) 751 7002 (215) 751 5419 Read All GlaxoSmithKline Press Releases Pharmaceutical Jobs Let Employers Fight Over You. You're in Control. Custom Job Match

More Press Releases

• Istanbul bomb blasts - update • Boeing Propulsion System Nails Critical Defense System Tests • Wayne Andrews, Director of Technology, Application Technology Group, Wins Pioneer Award • CADBURY SCHWEPPES REPORTS RESILIENT PERFORMANCE IN TRANSITION YEAR - RESULTS IN LINE WITH EXPECTATIONS • Ethiopian Airlines Receives New Boeing 767-300ER and 737-700

Partners Finance News Today | Internet Phone | Master the Markets | Forex Blog | Forex Trading Systems | Compare CRM Software | Silver Investment News | Personal Finance Tips |

ICAA.EU | Corporate Archive | All News, Press Releases, Articles And Copyrights Belong To The Original Authors

http://www.icaa.eu/company/GlaxoSmithKline/article/7897.html 8/23/2007